Notice2024-24133
Charter Renewal of the Advisory Committee on Blood and Tissue Safety and Availability
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 18, 2024
Issuing agencies
Health and Human Services Department
Abstract
The Department of Health and Human Services is hereby giving notice that the charter for the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) has been renewed.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 202 (Friday, October 18, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 202 (Friday, October 18, 2024)]
[Notices]
[Page 83894]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-24133]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Charter Renewal of the Advisory Committee on Blood and Tissue
Safety and Availability
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services is hereby giving
notice that the charter for the Advisory Committee on Blood and Tissue
Safety and Availability (ACBTSA) has been renewed.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the ACBTSA; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Tower Building, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: (202) 795-7608. Email: <a href="/cdn-cgi/l/email-protection#18595b5a4c4b595870706b367f776e"><span class="__cf_email__" data-cfemail="b5f4f6f7e1e6f4f5ddddc69bd2dac3">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The ACBTSA is a non-discretionary federal
advisory committee. The ACBTSA is authorized under 42 U.S.C. 217a,
section 222 of the Public Health Service (PHS) Act, as amended. The
Committee is governed by the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. App),
which sets forth standards for the formation and use of advisory
committees. The ACBTSA advises, assists, consults with, and makes
policy recommendations to the Secretary, through the Assistant
Secretary for Health, regarding broad responsibilities related to the
safety of blood, blood products, tissues, and organs. For solid organs
and blood stem cells, the Committee's work is limited to policy issues
related to donor derived infectious disease complications of
transplantation.
To carry out its mission, the ACBTSA provides advice to the
Secretary through the Assistant Secretary for Health on a range of
policy issues which includes: (1) identification of public health
issues through surveillance of blood and tissue safety issues with
national biovigilance data tools; (2) identification of public health
issues that affect availability of blood, blood products, and tissues;
(3) broad public health, ethical, and legal issues related to the
safety of blood, blood products, and tissues; (4) the impact of various
economic factors (e.g., product cost and supply) on safety and
availability of blood, blood products, and tissues; (5) risk
communications related to blood transfusion and tissue transplantation;
and (6) identification of infectious disease transmission issues for
blood, organs, blood stem cells and tissues.
On September 25, 2024, the Secretary approved for the ACBTSA
charter to be renewed. Renewal of the Committee's charter gives
authorization for the Committee to continue to operate until October 9,
2026.
A copy of the ACBTSA charter is available on the Committee's
website at <a href="https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/charter/index.html">https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/charter/index.html</a>.
Dated: October 3, 2024.
James J. Berger,
DFO, Advisory Committee on Blood and Tissue Safety and Availability,
Office of Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2024-24133 Filed 10-17-24; 8:45 am]
BILLING CODE 4150-41-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 18, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.